Okay. So I believe the increase in other expenses was due to that maintenance costs? Also any idea how much of the NCDs will be used for repayment vs capacity expansion?
Posts tagged Value Pickr
NCL Industries – Resumption of growth? (17-11-2015)
I believe there was maintenance in Q2 due to which plant was shutdown and for the rest part of the quarter the capacity was 72%.
If they issue NCDs, they are going to pay off the debt and would be out of CDR. NCDs would be at lower interest rates so finance cost would be lower.
NCL Industries – Resumption of growth? (17-11-2015)
Thanks Sri Krishna. In Q1 capacity utilization was around 60-65% so I am a little surprised now with Q2 results where the utilization was higher. Is it solely due to lower realizations like other boarders have mentioned??
Secondly, as per debt covenants they were not allowed to expand capacity. They are not out of CDR yet. How is it they are going for expansion now? Also I believe the cycle of expansion for south Indian cement companies was over. Issuing NCDs for the same can disturb the balance sheet and demand/production balance. Now these cement companies in the south work as a cartel. How will this expansion impact it?
Can fellow boarders help me understand this please? Am I missing out on something? TIA
Disc: Invested
Torrent Pharma Ltd (17-11-2015)
thanks for the link.
this might allow torrent to extract some more juice from the abilify opportunity.
Ujaas Energy – Value Migration to Solar Power (17-11-2015)
Ujaas bags a 6MW order from Daman & Diu's Electricity Department.
http://www.bseindia.com/corporates/anndet_new.aspx?newsid=2ada1a4e-4f90-4d57-8500-2a9d5951e8f3.
As per the BSE filing, its 4th order win in last 6 months. Ujaas on slow and steady *win the race mode.
Disc : Invested.
Page industries (17-11-2015)
Being a value investor, I have not ventured into buying Growth stocks in the past 4-6 years. Whenever I have bought Growth stocks at fair or high valuations, have received not so optimum returns and have moved back to value investing.
MOST is good at researching into growth stocks, and do give recommendations at high valuations but some of those in the past have proven quite not so good. Some of the highly valued stocks in IT such as TechM, HCL Tech have corrected once their growth suddenly drops from above normal to below normal, so one has to be very cautious if you are paying for PE of 50 and above.
My assessment is that, competition is increasing in all sectors and some of the decent 30%-35% growth stories are seen suffering today with modest 20-25% growth and have not sustained high 50+ PE valuations for long time. It looks tough that, 35% growth will be sustained by PAGE for next 8-10 years to justify such high valuations. Being a cautious investor, I may sound pessimistic, but Mr. Market sometimes in sad mood can bring down valuations of strong business to realistic levels.
Page industries (17-11-2015)
Being a value investor, I have not ventured into buying Growth stocks in the past 4-6 years. Whenever I have bought Growth stocks at fair or high valuations, have received not so optimum returns and have moved back to value investing.
MOST is good at researching into growth stocks, and do give recommendations at high valuations but some of those in the past have proven quite not so good. Some of the highly valued stocks in IT such as TechM, HCL Tech have corrected once their growth suddenly drops from above normal to below normal, so one has to be very cautious if you are paying for PE of 50 and above.
My assessment is that, competition is increasing in all sectors and some of the decent 30%-35% growth stories are seen suffering today with modest 20-25% growth and have not sustained high 50+ PE valuations for long time. It looks tough that, 35% growth will be sustained by PAGE for next 8-10 years to justify such high valuations. Being a cautious investor, I may sound pessimistic, but Mr. Market sometimes in sad mood can bring down valuations of strong business to realistic levels.
Torrent Pharma Ltd (17-11-2015)
samirhuli,
Regarding pharma stocks I am not too sure at this stage which co from among the ones u mentioned is going to create the max wealth. But most of the US facing pharma companies who dont have regulatory hurdles are sitting pretty and are on track to make decent gains in next few years.
Regarding your comments about missing the bus, in case of the stock you are tracking or the girl you are wooing, its never too late to take the plunge. 
Torrent Pharma Ltd (17-11-2015)
samirhuli,
Regarding pharma stocks I am not too sure at this stage which co from among the ones u mentioned is going to create the max wealth. But most of the US facing pharma companies who dont have regulatory hurdles are sitting pretty and are on track to make decent gains in next few years.
Regarding your comments about missing the bus, in case of the stock you are tracking or the girl you are wooing, its never too late to take the plunge.
REPCO home finance – another Gruh in the making? (17-11-2015)
In investing,
- Sometimes, apart from theoretical knowledge, logic and common sense will be of great help.
- Sometimes, microscopic view does not give broader picture, you will only see electrons/protons rotating around nucleus, take a lift and see from 10th floor, you might see a beautiful picture.
This is not pointed towards anyone, just my view based on my experience.